Raymond James & Associates Kura Oncology, Inc. Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 14, 2023	BUY	$10.71 - $14.6 $13,623 - $18,571	1,272 Added 8.11%	16,961 $207,000
Q4 2022 Feb 08, 2023	SELL	$11.23 - $16.9 $17,810 - $26,803	-1,586 Reduced 9.18%	15,689 $194,000
Q3 2022 Oct 25, 2022	SELL	$12.01 - $19.45 $3,326 - $5,387	-277 Reduced 1.58%	17,275 $236,000
Q2 2022 Aug 12, 2022	SELL	$10.71 - $18.33 $492 - $843	-46 Reduced 0.26%	17,552 $322,000
Q1 2022 May 11, 2022	BUY	$11.78 - $16.98 $32,477 - $46,813	2,757 Added 18.58%	17,598 $283,000
Q4 2021 Feb 08, 2022	SELL	$12.22 - $19.57 $36,635 - $58,670	-2,998 Reduced 16.81%	14,841 $208,000
Q3 2021 Nov 02, 2021	SELL	$15.42 - $21.72 $6,969 - $9,817	-452 Reduced 2.47%	17,839 $334,000
Q2 2021 Aug 11, 2021	SELL	$20.85 - $29.88 $750 - $1,075	-36 Reduced 0.2%	18,291 $381,000
Q1 2021 May 14, 2021	SELL	$24.75 - $39.14 $23,661 - $37,417	-956 Reduced 4.96%	18,327 $518,000
Q4 2020 Feb 12, 2021	SELL	$29.0 - $41.62 $18,995 - $27,261	-655 Reduced 3.29%	19,283 $630,000
Q3 2020 Nov 04, 2020	BUY	$16.3 - $30.64 $16,756 - $31,497	1,028 Added 5.44%	19,938 $611,000
Q2 2020 Jul 28, 2020	BUY	$7.95 - $18.81 $12,942 - $30,622	1,628 Added 9.42%	18,910 $308,000
Q1 2020 Apr 21, 2020	SELL	$6.45 - $14.04 $7,423 - $16,160	-1,151 Reduced 6.24%	17,282 $172,000
Q4 2019 Feb 12, 2020	SELL	$12.97 - $15.94 $3,060 - $3,761	-236 Reduced 1.26%	18,433 $253,000
Q3 2019 Nov 07, 2019	SELL	$14.75 - $20.87 $3,333 - $4,716	-226 Reduced 1.2%	18,669 $283,000
Q2 2019 Aug 06, 2019	SELL	$14.71 - $19.79 $67,592 - $90,935	-4,595 Reduced 19.56%	18,895 $372,000
Q1 2019 May 06, 2019	BUY	$13.73 - $16.87 $36,741 - $45,144	2,676 Added 12.86%	23,490 $390,000
Q4 2018 Feb 11, 2019	SELL	$10.6 - $17.49 $51,134 - $84,371	-4,824 Reduced 18.82%	20,814 $292,000
Q3 2018 Nov 14, 2018	BUY	$16.65 - $21.85 $426,872 - $560,190	25,638 New	25,638 $449,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$68.4 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.3 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$51.9 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.4 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$38.7 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account